CXCR5 and rheumatoid arthritis: Further subgroup analysis based on antibody levels revealed significant differences in CXCR5 circulating methylation levels between patients with RA (whether RA‐DP, RA‐DN, RF‐ or CCP‐group) and patients with AS.